Anuradha Chakravarthy
Faculty Member
Last active: 3/30/2020

  1. Radiation-mediated control of drug delivery. Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C, Giorgio T (2001) Am J Clin Oncol 24(5): 473-80
    › Primary publication · 11586099 (PubMed)
  2. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC. Choy H, Chakravarthy A, Devore RF, Jagasia M, Hande KR, Roberts JR, Johnson DH, Yunus F (2000) Oncology (Williston Park) 14(7 Suppl 5): 43-6
    › Primary publication · 10981290 (PubMed)
  3. A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer. Chakravarthy A, Nicholson B, Kelley M, Beauchamp D, Johnson D, Frexes-Steed M, Simpson J, Shyr Y, Pietenpol J (2000) Clin Breast Cancer 1(1): 68-71
    › Primary publication · 11899393 (PubMed)
  4. A phase I trial of outpatient weekly irinotecan/carboplatin and concurrent radiation for stage III unresectable non small-cell lung cancer: a Vanderbilt-Ingram Cancer Center Affiliate Network Trial. Chakravarthy A, Choy H (2000) Clin Lung Cancer 1(4): 310-1
    › Primary publication · 14733637 (PubMed)
  5. The role of radiation, with or without chemotherapy, in the management of NSCLC. Chakravarthy A, Johnson D, Choy H (1999) Oncology (Williston Park) 13(10 Suppl 5): 93-100
    › Primary publication · 10550832 (PubMed)